BIVIW
BIOVIE INC.
Key Financials
Revenue
$0
N/A
Total Assets
$14.3M
↓ 33.9%
Operating Income
$-22651733
↓ 25.4%
EPS (Diluted)
$-3.05
↑ 74.8%
Total Liabilities
$4.0M
↑ 56.1%
Long-term Debt
$62500.00
0.0%
Net Income
$-22072863
↓ 25.8%
Operating Cash Flow
$-19024806.00
↑ 0.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEF 14A | 9/28/2026 | View on SEC |
| 8-K | 9/14/2026 | View on SEC |
| 424B5 | 9/14/2026 | View on SEC |
| SCHEDULE 13G | 9/3/2026 | View on SEC |
| 4 | 8/28/2026 | View on SEC |
| 4 | 8/28/2026 | View on SEC |
| 4 | 8/28/2026 | View on SEC |
| 4 | 8/28/2026 | View on SEC |
| SCHEDULE 13G | 8/19/2026 | View on SEC |
| S-1/A | 8/14/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BIVIW |
| Company Name | BIOVIE INC. |
| CIK | 1580149 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | NV |
| Phone | 775-888-3162 |